Correlation
The correlation between EHC and PFE is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
EHC vs. PFE
Compare and contrast key facts about Encompass Health Corporation (EHC) and Pfizer Inc. (PFE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: EHC or PFE.
Performance
EHC vs. PFE - Performance Comparison
Loading data...
Key characteristics
EHC:
1.73
PFE:
-0.52
EHC:
2.45
PFE:
-0.67
EHC:
1.34
PFE:
0.92
EHC:
2.65
PFE:
-0.23
EHC:
10.01
PFE:
-0.97
EHC:
4.28%
PFE:
14.17%
EHC:
25.78%
PFE:
24.28%
EHC:
-99.73%
PFE:
-58.96%
EHC:
-0.59%
PFE:
-55.10%
Fundamentals
EHC:
$11.98B
PFE:
$134.23B
EHC:
$4.86
PFE:
$1.40
EHC:
24.47
PFE:
16.86
EHC:
2.17
PFE:
2.15
EHC:
5.55
PFE:
1.49
EHC:
$5.51B
PFE:
$62.46B
EHC:
$2.01B
PFE:
$42.09B
EHC:
$1.25B
PFE:
$16.71B
Returns By Period
In the year-to-date period, EHC achieves a 31.50% return, which is significantly higher than PFE's -9.49% return. Over the past 10 years, EHC has outperformed PFE with an annualized return of 15.37%, while PFE has yielded a comparatively lower 0.60% annualized return.
EHC
31.50%
6.74%
17.03%
44.23%
33.92%
16.77%
15.37%
PFE
-9.49%
2.48%
-7.04%
-12.62%
-20.51%
-4.25%
0.60%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
EHC vs. PFE — Risk-Adjusted Performance Rank
EHC
PFE
EHC vs. PFE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Encompass Health Corporation (EHC) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
EHC vs. PFE - Dividend Comparison
EHC's dividend yield for the trailing twelve months is around 0.55%, less than PFE's 7.33% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EHC Encompass Health Corporation | 0.55% | 0.51% | 0.90% | 1.34% | 1.72% | 1.35% | 1.59% | 1.69% | 1.98% | 2.28% | 3.36% | 2.03% |
PFE Pfizer Inc. | 7.33% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% | 3.34% |
Drawdowns
EHC vs. PFE - Drawdown Comparison
The maximum EHC drawdown since its inception was -99.73%, which is greater than PFE's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for EHC and PFE.
Loading data...
Volatility
EHC vs. PFE - Volatility Comparison
The current volatility for Encompass Health Corporation (EHC) is 4.13%, while Pfizer Inc. (PFE) has a volatility of 10.01%. This indicates that EHC experiences smaller price fluctuations and is considered to be less risky than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
EHC vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Encompass Health Corporation and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
EHC vs. PFE - Profitability Comparison
EHC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Encompass Health Corporation reported a gross profit of 693.10M and revenue of 1.46B. Therefore, the gross margin over that period was 47.6%.
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a gross profit of 10.87B and revenue of 13.72B. Therefore, the gross margin over that period was 79.3%.
EHC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Encompass Health Corporation reported an operating income of 267.00M and revenue of 1.46B, resulting in an operating margin of 18.4%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported an operating income of 2.79B and revenue of 13.72B, resulting in an operating margin of 20.3%.
EHC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Encompass Health Corporation reported a net income of 151.50M and revenue of 1.46B, resulting in a net margin of 10.4%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a net income of 2.97B and revenue of 13.72B, resulting in a net margin of 21.6%.